Nexstim Plc - Manager's Transactions Manager's
Post# of 301275
Manager's transactions, Helsinki, 13 December 2016, at 9.00 am
Person subject to the notification requirement Name: Järnefelt, Gustaf Position: Other Senior Manager Issuer Name: Nexstim Oyj LEI: 743700S7ZI0LNMHZ6Y27 Nature of the notification: INITIAL NOTIFICATION Reference number: 743700S7ZI0LNMHZ6Y27_20161209153820_3 Transaction date: 9 December 2016 Venue: FIRST NORTH FINLAND (FNFI) Instrument: SHARE ISIN: FI4000102678 Nature of the transaction: ACQUISITION Transaction details (1): Volume: 10,500 Unit price: 0.16000 EUR (2): Volume: 36,500 Unit price: 0.17000 EUR Aggregated transactions (2): Volume: 47,000 Average price: 0.16777 EUR
NEXSTIM PLC Martin Jamieson, Chairman and CEO
Further information is available on the website www.nexstim.com or by contacting:
Nexstim +447715163942 Martin Jamieson, Chairman and CEO martin.jamieson@nexstim.com UB Securities Oy (Certified Adviser) +358 (0)9 2538 0246
Consilium Strategic Communications +44 (0)20 3709 5700 Mary-Jane Elliott / Ivar Milligan nexstim@consilium-comms.com
About Nexstim Plc Nexstim is a medical technology company which has pioneered its technology in brain diagnostics with the Navigated Brain Stimulation (NBS) system as the first and only FDA-cleared and CE-marked navigated Transcranial Magnetic Stimulation (nTMS) system for pre-surgical mapping of the motor and speech cortices. Based on the same technology platform, the Company has developed a system called Navigated Brain Therapy (NBT®) which is CE-marked for chronic neuropathic pain, major depression and stroke therapy. Nexstim's shares are listed on Nasdaq First North Finland and Nasdaq First North Sweden. For more information please visit www.nexstim.com
(0)
(0)